CONMED Acquires In2Bones Global, Inc.

CONMED Acquires Biorez, Inc. to Expand Sports Medicine Bioinductive Scaffold Technology

August 9, 2022

Medical Devices

CONMED Corporation announced a definitive agreement to acquire privately held Biorez, Inc. in a cash-free, debt-free transaction for $85 million at closing, with up to $165 million in growth-based earnout payments over four years. CONMED expects the deal to close in early August 2022, and later announced completion of the acquisition.

Bioventus Acquires Bioness, Inc.

March 30, 2021

Medical Devices

Bioventus Inc. acquired Bioness, Inc. for $45 million in up-front consideration plus up to $65 million of contingent consideration, making Bioness a wholly‑owned subsidiary. The acquisition expands Bioventus' rehabilitation and neuromodulation product portfolio and R&D pipeline, and is expected to be accretive to revenue by leveraging Bioventus' global commercial infrastructure.

TEAM Technologies (Clearlake-backed) Acquires iiMED Medical Solutions from ACON Investments

January 12, 2022

Medical Devices

TEAM Technologies, a Clearlake Capital-backed specialty manufacturer, has acquired iiMED Medical Solutions from ACON Investments. iiMED is a nearshore manufacturer of FDA Class I & II consumable medical devices based in Amherst, New York with manufacturing in Reynosa, Mexico; the deal expands TEAM's medical device manufacturing capabilities and nearshore footprint. Financial terms were not disclosed.

Johnson & Johnson Completes Acquisition of Abiomed

December 22, 2022

Medical Devices

Johnson & Johnson completed its acquisition of Abiomed through a tender offer and subsequent merger, for an upfront payment of $380.00 per share in cash (enterprise value ~ $16.6 billion), plus a non-tradeable contingent value right (CVR) up to $35.00 per share based on milestones. Abiomed will operate as a standalone business within Johnson & Johnson’s MedTech segment.

DCN Dx Acquires Biomed Diagnostics

April 25, 2022

Medical Devices

DCN Dx has completed its acquisition of Biomed Diagnostics, Inc., a microbiological testing products company based in White City, Oregon. The deal expands DCN Dx's point-of-use testing and sampling capabilities across human, veterinary, food safety and environmental markets by adding Biomed's InPouch/InTray culture and transport product lines.

Envista Acquires Osteogenics Biomedical Business

May 17, 2022

Medical Devices

Envista Holdings Corporation entered into a definitive agreement to acquire Osteogenics Biomedical, Allotech LLC and OBI Biologics (collectively “Osteogenics”), a developer of regenerative dental bone grafting products sold primarily under the Cytoplast brand. The deal, subject to customary regulatory approvals and expected to close in the third quarter, expands Envista’s capabilities in regenerative solutions for periodontists, oral and maxillofacial surgeons and implant dentistry; the transaction is not subject to a financing condition or shareholder vote.